Results 51 to 60 of about 789 (146)
Exploring current and emerging therapies for porphyrias
Abstract Porphyrias are rare, mostly inherited disorders resulting from altered activity of specific enzymes in the haem synthesis pathway that lead to accumulation of pathway intermediates. Photocutaneous symptoms occur when excess amounts of photoreactive porphyrins circulate in the blood to the skin, whereas increases in potentially neurotoxic ...
Daniel Jericó +7 more
wiley +1 more source
Abstract Givosiran is a subcutaneously administered, liver‐targeted RNA interference (RNAi) therapeutic that has been approved for treating acute hepatic porphyria (AHP). Elevation in plasma homocysteine (hyperhomocysteinemia) has been reported in AHP patients, and treatment with givosiran has been reported to further increase homocysteine levels in ...
Mark A. Keibler +3 more
wiley +1 more source
Analysis of whole blood protoporphyrin and plasma porphyrin in patients on dapsone
Photodermatology, Photoimmunology &Photomedicine, Volume 40, Issue 2, March 2024.
Amrutha Haridas +2 more
wiley +1 more source
IntroductionVariegate porphyria (VP) is a rare metabolic disorder. Its diagnosis is challenging when cutaneous features are absent and symptoms overlap with common conditions like diabetic neuropathy.Case presentationWe report a 71-year-old female with a
XiaoLi Yan +6 more
doaj +1 more source
Swiss patients with variegate porphyria have unique mutations
X Schneider-Yin, EI Minder
doaj +1 more source
Posterior Reversible Encephalopathy Syndrome in a Patient with Variegate Porphyria: A Case Report. [PDF]
Rasheed F +3 more
europepmc +1 more source
Liver graft as a 'Trojan horse': manifestation of variegate porphyria in an 11-month-old girl with biliary atresia after living-related liver transplantation. [PDF]
Stölzel U +5 more
europepmc +1 more source
Neurovisceral Syndrome in a Patient with Monoclonal Gammopathy of Undetermined Significance: A Confirmed Case of Variegate Porphyria. [PDF]
Fatima I +4 more
europepmc +1 more source

